Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE3.8350
- TODAY'S CHANGE (%)-0.0950 (-2.4173%)
- Bid / Lots3.9000/ 5
- Ask / Lots3.9700/ 39
- Open / Previous Close3.9400 / 3.9300
- Day Range
- 52 Week Range
- Volume947,340
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 8901 | 4 |
| 09:34 ET | 2072 | 3.98 |
| 09:36 ET | 6269 | 4.03 |
| 09:38 ET | 3327 | 4.01 |
| 09:39 ET | 4244 | 4.03 |
| 09:41 ET | 5381 | 3.98 |
| 09:43 ET | 1794 | 4 |
| 09:45 ET | 2800 | 4.01 |
| 09:50 ET | 900 | 4 |
| 09:52 ET | 1994 | 3.99 |
| 09:54 ET | 1065 | 3.9854 |
| 09:56 ET | 2845 | 3.94 |
| 09:57 ET | 553 | 3.97 |
| 10:01 ET | 3850 | 4 |
| 10:03 ET | 100 | 3.99 |
| 10:06 ET | 200 | 3.99 |
| 10:08 ET | 1801 | 3.98 |
| 10:10 ET | 1300 | 3.97 |
| 10:12 ET | 2100 | 3.97 |
| 10:14 ET | 1501 | 3.96 |
| 10:15 ET | 1700 | 3.94 |
| 10:17 ET | 1843 | 3.95 |
| 10:19 ET | 2692 | 3.9475 |
| 10:24 ET | 6841 | 3.945 |
| 10:26 ET | 100 | 3.95 |
| 10:30 ET | 5430 | 3.94 |
| 10:32 ET | 979 | 3.945 |
| 10:33 ET | 975 | 3.94 |
| 10:35 ET | 4277 | 3.945 |
| 10:37 ET | 500 | 3.94 |
| 10:39 ET | 600 | 3.94 |
| 10:44 ET | 100 | 3.94 |
| 10:46 ET | 1300 | 3.93 |
| 10:48 ET | 1100 | 3.9286 |
| 10:50 ET | 3840 | 3.925 |
| 10:51 ET | 1000 | 3.92 |
| 10:53 ET | 300 | 3.93 |
| 10:57 ET | 200 | 3.9397 |
| 11:00 ET | 300 | 3.935 |
| 11:02 ET | 200 | 3.935 |
| 11:04 ET | 200 | 3.94 |
| 11:06 ET | 1300 | 3.94 |
| 11:11 ET | 100 | 3.95 |
| 11:13 ET | 3192 | 3.95 |
| 11:15 ET | 700 | 3.94 |
| 11:22 ET | 1000 | 3.94 |
| 11:24 ET | 100 | 3.9399 |
| 11:26 ET | 300 | 3.935 |
| 11:29 ET | 900 | 3.93 |
| 11:31 ET | 700 | 3.93 |
| 11:36 ET | 105 | 3.93 |
| 11:38 ET | 200 | 3.93 |
| 11:42 ET | 200 | 3.93 |
| 11:44 ET | 8390 | 3.925 |
| 11:45 ET | 9592 | 3.9 |
| 11:51 ET | 5513 | 3.88 |
| 11:54 ET | 6898 | 3.89 |
| 11:58 ET | 100 | 3.9 |
| 12:00 ET | 400 | 3.9 |
| 12:03 ET | 750 | 3.905 |
| 12:07 ET | 1500 | 3.9 |
| 12:12 ET | 100 | 3.9 |
| 12:16 ET | 613 | 3.895 |
| 12:20 ET | 1751 | 3.9 |
| 12:21 ET | 1153 | 3.904 |
| 12:23 ET | 2962 | 3.885 |
| 12:25 ET | 1797 | 3.88 |
| 12:27 ET | 2100 | 3.875 |
| 12:30 ET | 3800 | 3.885 |
| 12:32 ET | 300 | 3.88 |
| 12:34 ET | 300 | 3.88 |
| 12:36 ET | 1599 | 3.88 |
| 12:38 ET | 2300 | 3.885 |
| 12:39 ET | 1891 | 3.87 |
| 12:41 ET | 868 | 3.86 |
| 12:43 ET | 7943 | 3.85 |
| 12:48 ET | 4813 | 3.85 |
| 12:50 ET | 1733 | 3.85 |
| 12:52 ET | 2240 | 3.83 |
| 12:54 ET | 600 | 3.83 |
| 12:56 ET | 2156 | 3.83 |
| 12:57 ET | 1525 | 3.825 |
| 12:59 ET | 495 | 3.82 |
| 01:01 ET | 11600 | 3.83 |
| 01:03 ET | 1506 | 3.83 |
| 01:06 ET | 2519 | 3.835 |
| 01:08 ET | 2039 | 3.855 |
| 01:10 ET | 1391 | 3.85 |
| 01:12 ET | 3734 | 3.8499 |
| 01:14 ET | 200 | 3.85 |
| 01:15 ET | 600 | 3.84 |
| 01:17 ET | 5200 | 3.85 |
| 01:19 ET | 18509 | 3.86 |
| 01:21 ET | 1052 | 3.86 |
| 01:24 ET | 8300 | 3.87 |
| 01:26 ET | 4100 | 3.87 |
| 01:30 ET | 700 | 3.87 |
| 01:32 ET | 200 | 3.8784 |
| 01:33 ET | 1608 | 3.875 |
| 01:35 ET | 5506 | 3.875 |
| 01:37 ET | 700 | 3.875 |
| 01:39 ET | 800 | 3.875 |
| 01:42 ET | 4675 | 3.875 |
| 01:44 ET | 4286 | 3.87 |
| 01:46 ET | 14153 | 3.85 |
| 01:50 ET | 1300 | 3.855 |
| 01:51 ET | 100 | 3.855 |
| 01:53 ET | 1200 | 3.85 |
| 01:55 ET | 2211 | 3.8591 |
| 01:57 ET | 2673 | 3.86 |
| 02:00 ET | 2855 | 3.85 |
| 02:02 ET | 1800 | 3.85 |
| 02:04 ET | 590 | 3.84 |
| 02:06 ET | 100 | 3.8479 |
| 02:08 ET | 1331 | 3.8417 |
| 02:09 ET | 395 | 3.85 |
| 02:11 ET | 3240 | 3.845 |
| 02:13 ET | 1613 | 3.85 |
| 02:15 ET | 2757 | 3.845 |
| 02:18 ET | 500 | 3.845 |
| 02:20 ET | 1800 | 3.845 |
| 02:22 ET | 4404 | 3.8523 |
| 02:24 ET | 400 | 3.85 |
| 02:26 ET | 1647 | 3.86 |
| 02:27 ET | 1080 | 3.855 |
| 02:29 ET | 421 | 3.86 |
| 02:31 ET | 1662 | 3.86 |
| 02:33 ET | 200 | 3.855 |
| 02:36 ET | 988 | 3.855 |
| 02:38 ET | 512 | 3.855 |
| 02:40 ET | 3706 | 3.845 |
| 02:42 ET | 795 | 3.85 |
| 02:44 ET | 400 | 3.85 |
| 02:47 ET | 1100 | 3.855 |
| 02:49 ET | 1045 | 3.86 |
| 02:51 ET | 300 | 3.855 |
| 02:54 ET | 900 | 3.855 |
| 02:56 ET | 300 | 3.855 |
| 02:58 ET | 11986 | 3.86 |
| 03:00 ET | 15661 | 3.87 |
| 03:02 ET | 40382 | 3.906 |
| 03:03 ET | 7279 | 3.91 |
| 03:05 ET | 3010 | 3.905 |
| 03:07 ET | 100 | 3.905 |
| 03:09 ET | 15222 | 3.985 |
| 03:12 ET | 8987 | 3.9941 |
| 03:14 ET | 3252 | 3.9896 |
| 03:18 ET | 7597 | 3.995 |
| 03:20 ET | 8139 | 4.025 |
| 03:21 ET | 5963 | 4 |
| 03:23 ET | 1769 | 3.985 |
| 03:25 ET | 385 | 3.9825 |
| 03:27 ET | 1356 | 3.9872 |
| 03:30 ET | 6543 | 3.995 |
| 03:32 ET | 2300 | 3.995 |
| 03:34 ET | 4099 | 3.995 |
| 03:36 ET | 4870 | 4 |
| 03:38 ET | 5900 | 3.995 |
| 03:39 ET | 5345 | 3.99 |
| 03:41 ET | 2525 | 3.99 |
| 03:43 ET | 11865 | 3.99 |
| 03:45 ET | 10422 | 3.99 |
| 03:48 ET | 5517 | 3.99 |
| 03:50 ET | 6989 | 3.977 |
| 03:52 ET | 12901 | 3.94 |
| 03:54 ET | 12076 | 3.9182 |
| 03:56 ET | 40931 | 3.88 |
| 03:57 ET | 13628 | 3.88 |
| 03:59 ET | 244972 | 3.835 |
Today
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX), from 5 hours ago by Dow Jones
5 hours ago by Dow JonesVTYX DEADLINE TOMORROW: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesLevi & Korsinsky Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX, from 8 hours ago by Dow Jones
8 hours ago by Dow JonesVTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX, from 9 hours ago by Dow Jones
9 hours ago by Dow Jones
Yesterday
Contact Levi & Korsinsky by April 30, 2024 Deadline to Join Class Action Against Ventyx Biosciences, Inc.(VTYX), from 8:02PM ET on Sunday Apr 28, 2024 by Dow Jones
8:02PM ET on Sunday Apr 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 276.8M | -1.2x | --- |
Avenue Therapeutics Inc | 274.4M | 0.0x | --- |
Inozyme Pharma Inc | 274.3M | -3.2x | --- |
Zura Bio Ltd | 280.8M | -1.1x | --- |
RAPT Therapeutics Inc | 281.9M | -2.6x | --- |
Anavex Life Sciences Corp | 282.5M | -6.8x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Scientific Officer
- John Nuss
- Independent Director
- Onaiza Cadoret-manier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $276.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.29 |
Book Value | $4.12 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
